Outlook Therapeutics (OTLK) Depreciation and Depletion: 2019-2020
Historic Depreciation and Depletion for Outlook Therapeutics (OTLK) over the last 1 years, with Sep 2020 value amounting to $40,906.
- Outlook Therapeutics' Depreciation and Depletion was N/A to $40,906 in Q3 2020 from the same period last year, while for Sep 2020 it was $219,416, marking a year-over-year change of. This contributed to the annual value of $163,625 for FY2022, which is negligibly% changed negligibly from last year.
- As of Q3 2020, Outlook Therapeutics' Depreciation and Depletion stood at $40,906, which was down 19.73% from $50,959 recorded in Q2 2020.
- Outlook Therapeutics' Depreciation and Depletion's 5-year high stood at $63,776 during Q4 2019, with a 5-year trough of $40,906 in Q3 2020.
- In the last 2 years, Outlook Therapeutics' Depreciation and Depletion had a median value of $57,367 in 2020 and averaged $54,854.